NYSE:PFEPharmaceuticals
Pfizer (PFE) Agrees To $44 Million Class Action Settlement
Pfizer (NYSE:PFE) agreed to a US$44 million class action settlement related to its Chantix smoking cessation drug.
The settlement addresses allegations that Chantix contained undisclosed carcinogenic nitrosamines.
The agreement follows consumer litigation focused on product safety disclosures and potential health risks.
To see how other large pharmaceutical stocks manage product liability and regulatory risk, review 49 high quality undervalued stocks.
NYSE:PFE 1-Year Stock Price...